17-18487709-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000328114.11(LGALS9C):c.396C>A(p.Asp132Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,557,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000078 ( 0 hom., cov: 21)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
LGALS9C
ENST00000328114.11 missense
ENST00000328114.11 missense
Scores
2
5
11
Clinical Significance
Conservation
PhyloP100: 1.30
Genes affected
LGALS9C (HGNC:33874): (galectin 9C) This gene was initially thought to represent a pseudogene of galectin 9; however, this transcript has good exon-intron structure and encodes a predicted protein of the same size as and highly similar to galectin 9. This gene is one of two similar loci on chromosome 17p similar to galectin 9 and now thought to be protein-encoding. This gene is the more telomeric gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.39117005).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LGALS9C | NM_001040078.3 | c.396C>A | p.Asp132Glu | missense_variant | 4/11 | ENST00000328114.11 | NP_001035167.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS9C | ENST00000328114.11 | c.396C>A | p.Asp132Glu | missense_variant | 4/11 | 1 | NM_001040078.3 | ENSP00000329932 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000783 AC: 11AN: 140546Hom.: 0 Cov.: 21
GnomAD3 genomes
AF:
AC:
11
AN:
140546
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000173 AC: 4AN: 230628Hom.: 0 AF XY: 0.0000240 AC XY: 3AN XY: 124824
GnomAD3 exomes
AF:
AC:
4
AN:
230628
Hom.:
AF XY:
AC XY:
3
AN XY:
124824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000141 AC: 20AN: 1417316Hom.: 0 Cov.: 31 AF XY: 0.0000114 AC XY: 8AN XY: 704664
GnomAD4 exome
AF:
AC:
20
AN:
1417316
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
704664
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000782 AC: 11AN: 140630Hom.: 0 Cov.: 21 AF XY: 0.0000730 AC XY: 5AN XY: 68456
GnomAD4 genome
AF:
AC:
11
AN:
140630
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
68456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.396C>A (p.D132E) alteration is located in exon 4 (coding exon 4) of the LGALS9C gene. This alteration results from a C to A substitution at nucleotide position 396, causing the aspartic acid (D) at amino acid position 132 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;.;M;.;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D;.;.
REVEL
Benign
Sift
Uncertain
.;.;D;.;.
Sift4G
Uncertain
D;D;D;D;D
Polyphen
0.94
.;.;P;.;.
Vest4
MutPred
Loss of catalytic residue at N137 (P = 0.1736);Loss of catalytic residue at N137 (P = 0.1736);Loss of catalytic residue at N137 (P = 0.1736);Loss of catalytic residue at N137 (P = 0.1736);Loss of catalytic residue at N137 (P = 0.1736);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at